首页> 外国专利> HUMANIZED ANTI-IGE ANTIBODIES THAT CROSSLINK CD23 ON B LYMPHOCYTES BUT DO NOT SENSITIZE MAST CELLS

HUMANIZED ANTI-IGE ANTIBODIES THAT CROSSLINK CD23 ON B LYMPHOCYTES BUT DO NOT SENSITIZE MAST CELLS

机译:B淋巴细胞上的CD23交联但未敏化肥大细胞的人源化抗体

摘要

A novel humanized anti-IgE antibody is disclosed. The antibody is capable of binding to free IgE, membrane-bound IgE on B lymphocytes, IgE bound by CD23, but not to IgE bound by high-affinity IgE.Fc receptor on mast cells. The present invention relates to the treatment of IgE-mediated diseases, including allergic asthma, allergic rhinitis, atopic dermatitis, food allergy, chronic spontaneous (idiopathic) urticaria, chronic rhinosinusitis, systemic mastocytosis, cutaneous mastocytosis, allergic bronchopulmonary aspergillosis, recurrent idiopathic angioedema, and eosinophil-associated gastrointestinal disorder by administering the anti-IgE antibody of the present invention.
机译:公开了新型的人源化抗IgE抗体。该抗体能够与游离的IgE,B淋巴细胞上的膜结合IgE,CD23结合的IgE结合,但不与肥大细胞上的高亲和力IgE.Fc受体结合的IgE结合。本发明涉及IgE介导的疾病的治疗,包括变应性哮喘,变应性鼻炎,特应性皮炎,食物过敏,慢性自发性(特发性)荨麻疹,慢性鼻-鼻窦炎,系统性肥大细胞增多症,皮肤肥大细胞增多症,过敏性支气管肺曲霉病,复发性特发性虹膜炎通过给予本发明的抗IgE抗体,可以解决与嗜酸性粒细胞相关的胃肠道疾病。

著录项

  • 公开/公告号CA2943588C

    专利类型

  • 公开/公告日2019-04-30

    原文格式PDF

  • 申请/专利权人 ACADEMIA SINICA;

    申请/专利号CA20152943588

  • 发明设计人 CHEN JIUN-BO;SHIUNG YU-YU;CHANG TSE-WEN;

    申请日2015-06-16

  • 分类号C07K16;A61K39/395;C07K16/42;C07K16/46;

  • 国家 CA

  • 入库时间 2022-08-21 11:59:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号